2014-02-112014-02-112011TEIXEIRA, José Ribamar Mesquita. Avaliação da terapêutica da malária por Plasmodium vivax: perfil cinético da cloroquina e primaquina. 2011. 95 f. Tese (Doutorado) - Universidade Federal do Pará, Instituto de Ciências Biológicas, Belém, 2011. Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários.https://repositorio.ufpa.br/handle/2011/4753Today search - new strategies for improving the treatment and control of malaria. The monitoring of plasma concentrations of drugs is an important tool that aims to provide more knowledge on the kinetics of several antimalarial drugs, aiming to achieve rapid therapeutic effect with reduced risk of toxicity. Thus, this study aimed to evaluate the therapeutic response to chloroquine and primaquine for vivax malaria patients, the plasma concentrations correlate with parasitemia, epidemiological data and evaluation of liver and kidney function, aiming at the optimization of various therapeutic regimens employed, evaluating if the responses are due to ineffective treatment of Plasmodium resistance to chloroquine or the presence of sub-therapeutic concentrations of drugs. Thus, we evaluated 40 patients with vivax malaria in the Program in Clinical Trials of Malaria Institute Evandro Chagas (Belém, Pará) in the period 2008 to 2010. Hemogram and other biochemical parameters were performed. The research of plasmodia in blood smear was performed and the parasitemia averaged 7187.5 ± 6732.7 parasitos/mm3. The prevalence of males with 67.5% of cases. The locations of malaria infection ranged from 14 municipalities in the state of Pará, most of which originates in the city of Anajás. For 42.5% of patients it was the first episode of the disease and 57.5% of applicants. In the evaluation of anemia by hemoglobin, there - if the levels below reference values in 60% of patients and hematological and biochemical parameters showed that the mean values of hematocrit and red blood cells showed highly significant difference between subgroups of patients and non-anemic anemic. The determination of chloroquine and primaquine in patients on D0, D2, D7, D14 and D30 were performed. The mean values of 0, 1102.1, 546.7, 185.8 and 98.6 ng / ml for chloroquine and 0, 210.2, 345.0, 91.7 and 0 ng/ml for primaquine.porAcesso AbertoMalária vivaxAntimaláricosPlasmodium vivaxCloroquinaPrimaquinaTerapêuticaPará - EstadoAmazônia brasileiraTeseCNPQ::CIENCIAS BIOLOGICAS::FARMACOLOGIA::FARMACOLOGIA GERAL::FARMACOCINETICA